| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C012729 |
2-amino-4-phosphonobutyric acid |
2-amino-4-phosphonobutyric acid results in increased expression of T mRNA | increases expression | 16806298
|
| D001151 |
Arsenic |
T mRNA results in increased susceptibility to Arsenic | increases response to substance | 17976673
|
| C091888 |
monoisoamyl-2,3-dimercaptosuccinate |
monoisoamyl-2,3-dimercaptosuccinate affects the expression of T mRNA | affects expression | 19615344
|
| C091888 |
monoisoamyl-2,3-dimercaptosuccinate |
monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of T mRNA] | decreases expression|decreases reaction | 19615344
|
| C408604 |
PD 169316 |
PD 169316 results in decreased expression of T mRNA | decreases expression | 14685156
|
| D020849 |
Raloxifene |
Raloxifene results in increased expression of T mRNA | increases expression | 16202921
|
| C017947 |
sodium arsenite |
monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of T mRNA] | decreases expression|decreases reaction | 19615344
|
| C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of T mRNA | decreases expression | 19615344
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.22 | 15276417 |
| MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
15.59 | 17306315 |
| MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
15.59 | 17306315 16712894 |
| MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.98 | 17308373 17451421 |
| MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.59 | 15800139 |
| MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.93 | 18414634 16251483 12569548 16835338 |
| MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.42 | 19371607 12928151 |
| MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.89 | 16580743 |
| MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.63 | 17261762 17595753 17893378 16837676 15758505 17049068 16912660 15775269 15572757 17440819 17952589 17242785 |
| MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.75 | 17687452 15504454 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
3.35 | 16507464 17306315 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
3.35 | 16507464 17306315 15276417 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
5.08 | 15504454 18922899 17687452 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
5.08 | 18572023 |
| MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
10.70 | 18640142 |
| MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
10.70 | 17572228 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
8.26 | 17938729 15738583 19152805 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
8.26 | 15775269 |
| MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.60 | 16973168 18022660 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
3.19 | 19524636 20056578 |
| MESH:D002817 |
Chordoma |
marker/mechanism |
|
| 19801981 |
| MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
5.04 | 15800139 |
| MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.45 | 17474826 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
4.22 | 15920148 17308373 17451421 |
| MESH:D004487 |
Edema |
|
Raloxifene |
3.66 | 15860553 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
4.38 | 15845917 |
| MESH:D005234 |
Fatty Liver |
|
Raloxifene |
3.95 | 17473493 |
| MESH:D005534 |
Foot Diseases |
|
Arsenic |
6.08 | 6392382 |
| MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.14 | 16452187 |
| MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.74 | 11110106 |
| MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.43 | 12676792 |
| MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.76 | 17050553 |
| MESH:D006973 |
Hypertension |
|
Arsenic |
5.91 | 11953799 16076760 9931084 |
| MESH:D006973 |
Hypertension |
|
Raloxifene |
5.91 | 17577099 15787275 |
| MESH:D006987 |
Hypesthesia |
|
Arsenic |
6.08 | 16093927 |
| MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.19 | 15346721 12646999 |
| MESH:D007642 |
Keratosis |
|
Arsenic |
5.45 | 12749816 16930632 |
| MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.96 | 20008137 |
| MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.85 | 16973256 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
3.74 | 17339181 |
| MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.60 | 11134558 |
| MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
5.13 | 16368122 |
| MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
5.13 | 16712894 15276417 |
| MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.37 | 19095001 |
| MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
2.73 | 19168569 17306315 17976673 |
| MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.73 | 19931552 17306315 16712894 15276417 17077188 |
| MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.06 | 19082730 16487513 |
| MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
6.08 | 15863610 |
| MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.65 | 16497877 |
| MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
4.24 | 15371236 |
| MESH:D009232 |
Myxoma |
|
Raloxifene |
6.08 | 16343187 |
| MESH:D009369 |
Neoplasms |
|
sodium arsenite |
2.63 | 11559025 |
| MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
4.08 | 20056578 |
| MESH:D009436 |
Neural Tube Defects |
marker/mechanism |
|
| |
| MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
8.10 | 16620997 |
| MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
8.10 | 12854658 |
| MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.73 | 17056641 |
| MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.57 | 17882678 15775268 19059307 |
| MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.58 | 15758505 15579764 17893378 17823083 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
5.30 | 17306315 |
| MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
5.30 | 15276417 17306315 |
| MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.56 | 16093927 |
| MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.45 | 6392382 16905509 15371236 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.63 | 16140617 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.63 | 16536755 15731164 16220300 |
| MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.63 | 16039940 |
| MESH:D011507 |
Proteinuria |
|
Arsenic |
4.35 | 21343184 |
| MESH:D011693 |
Purpura |
|
Raloxifene |
6.08 | 15770314 |
| MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.81 | 17938729 16353154 15952646 19834688 18709164 17050553 17453740 6392382 16702368 17548696 16759981 |
| MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
6.38 | 17029826 19538983 17050553 16251483 15504454 17976673 |
| MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
6.38 | 18572023 19524636 |
| MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
4.04 | 12854658 |
| MESH:D020521 |
Stroke |
|
Raloxifene |
4.08 | 16837676 |
| MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.73 | 19048282 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
9.06 | 17976673 17306315 19322015 19429237 11144890 18640142 15987713 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
9.06 | 17572228 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
9.06 | 11723127 17306315 16712894 16452187 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
4.07 | 11813266 |
| MESH:D014652 |
Vascular Diseases |
|
Arsenic |
13.44 | 17056641 |
| MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
13.44 | 17056641 |
| MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.73 | 16837676 |
| MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
6.08 | 16343187 |